Journal profile · Immunology
Immunity
ISSN 1074-7613 · eISSN 1097-4180 · Cell Press · UNITED STATES · Monthly
Immunity: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 30.48; hybrid open access; APC about USD 10,400; median 312 days to acceptance (93 articles, last 24 months); community-reported acceptance: about 50%; 260 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Immunity is published by Cell Press and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, T-cell and B-cell Immunology and Immunotherapy and Immune Responses, together about 54.1% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Immunity is a monthly journal which publishes research articles and reviews of general interest in the entire discipline of immunology. Immunity was founded in the belief that advances in molecular and cellular immunology have brought immunology to a point at which a journal of high quality should be able to provide a unifying intellectual view, but the mandate for Immunity is not restricted to any particular level of analysis or to any particular type of system. The title Immunity is meant to indicate a breadth of interest extending beyond the formal definition of immunology, and into all systems that contribute to, or interact with, the immune system of the organism.
Source: LetPub
Research area (LetPub): Immunology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Cell Function and InteractionImmunology and Microbiology22.8%
- T-cell and B-cell ImmunologyImmunology and Microbiology19.6%
- Immunotherapy and Immune ResponsesImmunology and Microbiology11.8%
- Immune Response and InflammationImmunology and Microbiology6.1%
- IL-33, ST2, and ILC PathwaysImmunology and Microbiology3.7%
- Immune cells in cancerImmunology and Microbiology3.7%
- interferon and immune responsesImmunology and Microbiology3.1%
- CAR-T cell therapy researchMedicine2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 30.48LetPub ·
- CiteScore 2026-06
- 44.9LetPub ·
- SJR 2026-06
- 16.48LetPub ·
- SNIP 2026-06
- 5.25LetPub ·
- h-index
- 355LetPub ·
- h-index
- 573OpenAlex ·
- i10-index
- 5,495OpenAlex ·
- 2-year mean citedness
- 24.88OpenAlex ·
- Self-citation rate
- 1.6%LetPub ·
- Share of gold OA articles
- 31.76%LetPub ·
Volume
- Articles per year
- 177LetPub ·
Articles by year OpenAlex count · 6,805 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 200 | 115 | 472 |
| 2025 | 260 | 170 | 4,794 |
| 2024 | 250 | 244 | 12,401 |
| 2023 | 239 | 239 | 16,833 |
| 2022 | 218 | 218 | 22,367 |
| 2021 | 252 | 249 | 30,069 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
312 daysMedian, submission to acceptance · P25–P75 198 days – 382 days
- Acceptance to online
- median 27 days (81 articles)
- Submission to online
- median 357 days
- Sample
- 93 articles with submission and acceptance dates (533 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 6 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 10,400 / EUR 9,640 / GBP 8,330 / JPY 1,289,910 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Cell Press
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- ISSN
- 1074-7613
- Electronic ISSN
- 1097-4180
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Immunity
What CAS zone is Immunity in?
In the 2025 upgraded edition of the CAS Journal Ranking, Immunity is in Zone 1 of Medicine, and in Zone 1 of the minor category Immunology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Immunity?
The latest impact factor listed by LetPub is 30.48; CiteScore 44.9, h-index 573.
How long does peer review take at Immunity?
Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 312 days (interquartile range 198–382 days); authors report an average review time of about 6 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Immunity?
According to LetPub and DOAJ records, Immunity is indexed in SCIE and Scopus.
Is Immunity open access, and what is the APC?
Immunity is a hybrid journal. For open-access publication: APC about USD 10,400.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .